Cme Group INC Form 4 insider transactions

Timothy S. Bitsberger, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Hilda Harris Piell, Sr. MD & Chief HR Officer at CME Group Inc., reported a transaction involving 5,753 shares of Common Stock Class A.

CME Group Chairman and CEO Terrence A. Duffy reported the sale of common stock valued at over $10 million.

CME Group director William R. Shepard acquired 1,469.84 Class A shares via dividend reinvestment at $297.38 on March 26, 2026.

CME Group's Senior MD General Counsel, Jonathan L. Marcus, filed an amended Form 4 to correct the reported sale price of 3,291 shares of common stock.

CME Group's Senior MD and General Counsel, Jonathan L. Marcus, sold 3,291 shares of Class A Common Stock for $333.37 per share under a pre-arranged 10b5-1 plan.

CME Group's Sr MD Global Head Equity & FX, Timothy Francis McCourt, reported the vesting of performance shares and subsequent tax-related dispositions.

CME Group's Senior Managing Director and General Counsel, Jonathan L. Marcus, reported the vesting of performance shares and subsequent share dispositions for tax obligations.

CME Group's Senior Managing Director and Chief HR Officer, Hilda Harris Piell, received 7,076 shares from a performance award and surrendered 3,039 shares for tax withholding.

CME Group's COO, Suzanne Sprague, reported the vesting of 5,504 performance shares and subsequent tax-related share disposals on March 15, 2026.

CME Group Chairman and CEO Terrence A. Duffy acquired 62,902 shares through performance share vesting and subsequently disposed of 27,866 shares for tax withholding obligations.

CME Group's Chief Transformation Officer, Ken Vroman, reported the vesting of performance shares and subsequent sale for tax obligations.

CME Group's Sr MD Chief Commercial Officer, Julie Winkler, received 8,256 shares from performance share vesting, while surrendering 3,658 shares for tax obligations.

CME Group Senior Managing Director Derek Sammann received performance shares and sold a portion for tax obligations.

CME Group's President and CFO, Lynne Fitzpatrick, reported the vesting of performance shares and subsequent tax-related share surrenders.

CME Group's Chief Accounting Officer, Jack J. Tobin, reported the vesting of performance shares and subsequent tax-related share disposition.

CME Group's Chief Information Officer, Sunil Cutinho, reported the vesting of 8,256 performance shares and the disposition of 3,658 shares for tax obligations.

CME Group's MD Chief Accounting Officer, Jack J. Tobin, reported gifting 105 shares of Common Stock Class A.

CME Group's Chief Transformation Officer, Ken Vroman, reported the sale of 5,160 shares of Class A common stock at an average price of $309 under a pre-arranged plan.

CME Group Inc. Director Bryan T. Durkin sold 4,200 shares of Class A common stock for approximately $309.65 per share on February 23, 2026, under a Rule 10b5-1 plan.

CME Group Inc. Director Dennis Suskind reported a future sale of 748 shares of Class A Common Stock at $300 per share, effective February 6, 2026.

CME Group Inc. Director William R. Shepard increased his beneficial ownership of Class A Common Stock through a dividend reinvestment plan on December 30, 2025.

CME Group Chairman and CEO Terrence A. Duffy disposed of 10,210 shares of Common Stock Class A on December 31, 2025, to cover tax withholding obligations related to restricted stock vesting.

CME Group Chairman and CEO Terrence A. Duffy sold 25,000 shares of Class A common stock for approximately $6.73 million through a pre-arranged trading plan.

Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc., reported the sale of 7,200 Class A common shares for approximately $1.98 million under a Rule 10b5-1 plan.

CME Group's Sr MD & Chief HR Officer, Hilda Harris Piell, reported gifting 973 shares of Common Stock Class A to her donor advised fund.

CME Group Inc. Director Harold Ford Jr. sold 1,000 shares of Class A common stock on November 3, 2025, for a weighted average price of $263.53.

CME Group Director William R. Shepard acquired additional Class A Common Stock through a dividend reinvestment plan on September 25, 2025.

Jonathan L. Marcus, CME Group's Senior Managing Director and General Counsel, sold 392 shares of Class A Common Stock for $262 per share pursuant to a pre-arranged Rule 10b5-1 plan.

CME Group's Chief Information Officer, Sunil Cutinho, reported changes in his beneficial ownership of Class A Common Stock, including acquisitions and dispositions related to restricted stock vesting and tax obligations.